Featured Research

from universities, journals, and other organizations

'Designer' sedative may provide new alternative for colonoscopy

Date:
October 28, 2013
Source:
Wolters Kluwer Health: Lippincott Williams Array Wilkins
Summary:
Developed using molecular-level techniques, the "designer" sedative drug remimazolam provides a promising new alternative for sedation in patients undergoing colonoscopy, reports a study.

Developed using molecular-level techniques, the "designer" sedative drug remimazolam provides a promising new alternative for sedation in patients undergoing colonoscopy, reports a study in the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

"Remimazolam has the attributes of a sedative drug, with success rates comparable with recent studies of other drugs," according to the new research, led by Dr Mark T. Worthington of Johns Hopkins Hospital, Baltimore.

Remimazolam Shows Fast Onset of Sedation and Quick Recovery

The researchers evaluated the use of remimazolam, a new benzodiazepine-type sedative drug, for sedation in patients undergoing colonoscopy. As described in a recent article in Anesthesia & Analgesia, remimazolam is an example of new anesthetic and sedative drugs being developed with the use of molecular-level techniques. Remimazolam was specifically designed to have a faster onset, more predictable effects, and shorter recovery time compared to currently available sedatives.

In the "dose-finding" study, 44 volunteers received one of three different doses of remimazolam. Across dose groups, remimazolam successfully provided an adequate level of sedation for colonoscopy in three-fourths of patients.

Remimazolam achieved adequate sedation less than one minute after drug administration. Afterwards, all subjects "rapidly recovered to fully alert" -- the median recovery time was less than 10 minutes.

A few subjects did not achieve adequate sedation or had minor adverse events, such as a drop in blood pressure. There were no serious or unexpected adverse events, however.

Further experiments showed that the sedative effect of remimazolam could be rapidly reversed using flumazenil -- an approved medication that blocks the benzodiazepine receptor. Patients regained full alertness within one minute after flumazenil injection.

Colonoscopy is commonly performed as a screening test for colorectal cancer. For this and other brief medical procedures, some form of sedative is needed to minimize patient discomfort and optimize performance of the procedure. The ideal sedative would have a fast onset and good quality of sedation, along with rapid recovery time.

Conventional benzodiazepines provide effective sedation but relatively long recovery times -- patients may not return to their normal level of alertness and functioning for several hours after the procedure. The new study is the first to compare the effects of various doses of remimazolam as sedative for colonoscopy.

The new results show "very encouraging" success rates with remimazolam, Dr Worthington and coauthors write. With its fast onset and quick recovery time -- including the ability to reverse sedation almost immediately, if needed -- remimazolam could be a valuable new sedative option for use in colonoscopy and other brief medical procedures. However, the researchers note that further studies will be needed to "refine the optimal dosing regimen" before remimazolam goes into widespread clinical use.


Story Source:

The above story is based on materials provided by Wolters Kluwer Health: Lippincott Williams Array Wilkins. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mark T. Worthington, Laurie J. Antonik, D. Ronald Goldwater, James P. Lees, Karin Wilhelm-Ogunbiyi, Keith M. Borkett, Mack C. Mitchell. A Phase Ib, Dose-Finding Study of Multiple Doses of Remimazolam (CNS 7056) in Volunteers Undergoing Colonoscopy. Anesthesia & Analgesia, 2013; 117 (5): 1093 DOI: 10.1213/ANE.0b013e3182a705ae

Cite This Page:

Wolters Kluwer Health: Lippincott Williams Array Wilkins. "'Designer' sedative may provide new alternative for colonoscopy." ScienceDaily. ScienceDaily, 28 October 2013. <www.sciencedaily.com/releases/2013/10/131028134746.htm>.
Wolters Kluwer Health: Lippincott Williams Array Wilkins. (2013, October 28). 'Designer' sedative may provide new alternative for colonoscopy. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2013/10/131028134746.htm
Wolters Kluwer Health: Lippincott Williams Array Wilkins. "'Designer' sedative may provide new alternative for colonoscopy." ScienceDaily. www.sciencedaily.com/releases/2013/10/131028134746.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins